Assistance Publique-Hôpitaux de Paris-Sorbonne (AP-HP-Sorbonne), Hôpital la Pitié-Salpêtrière, Service des Pathologies du Sommeil et Centre de Référence National des Narcolepsies et Hypersomnies rares, Paris, France.
Sorbonne University and Paris Brain Institute (ICM), Paris, France.
Sleep. 2023 May 10;46(5). doi: 10.1093/sleep/zsad032.
To evaluate sleep, sleepiness, and excessive need for sleep in patients with craniopharyngioma (a suprasellar tumor which can affect sleep-wake systems).
A retrospective study of all adult patients living with craniopharyngioma referred to the sleep clinic, who received a sleep interview, nocturnal polysomnography, multiple sleep latency tests (MSLT), and 18-h bed rest polysomnography. Their sleep measurements were compared with those of age- and sex-matched healthy controls.
Of 54 patients screened with craniopharyngioma, 42 were analyzed, 80% of whom complained of excessive daytime sleepiness. Sleep testing revealed that 6 (14.3%) of them had secondary narcolepsy (including one with cataplexy), and 11 (26.2%) had central hypersomnia associated with a medical disorder. Compared with controls, patients were more frequently obese, had a shorter mean sleep latency on MSLT, and slept longer on the first night. There was a nonsignificant trend for patients with (vs. without) narcolepsy and hypersomnia to be younger, to have a higher body mass index, to be more likely to have received radiation therapy, and to have more severe damage to the hypothalamus after surgery. Treatment with stimulants (modafinil, pitolisant, and methylphenidate) was beneficial in 9/10 patients.
Nearly half of the patients with craniopharyngioma and sleep disorders have a central disorder of hypersomnolence (narcolepsy and hypersomnia), which should be investigated and lead to considerations beyond sleep apnea syndrome in these obese patients.
评估颅咽管瘤(一种可影响睡眠-觉醒系统的鞍上肿瘤)患者的睡眠、嗜睡和过度睡眠需求。
对所有被转诊至睡眠诊所的患有颅咽管瘤的成年患者进行回顾性研究,这些患者接受了睡眠访谈、夜间多导睡眠图、多次小睡潜伏期试验(MSLT)和 18 小时卧床多导睡眠图检查。将他们的睡眠测量值与年龄和性别匹配的健康对照组进行比较。
在筛查出的 54 例颅咽管瘤患者中,有 42 例进行了分析,其中 80%的患者抱怨白天过度嗜睡。睡眠测试显示,其中 6 例(14.3%)患有继发性发作性睡病(包括 1 例伴有猝倒),11 例(26.2%)患有与医学疾病相关的中枢性嗜睡症。与对照组相比,患者更常肥胖,MSLT 的平均潜伏期更短,第一晚睡眠时间更长。存在一种无显著性趋势,即患有(与不患有)发作性睡病和中枢性嗜睡症的患者更年轻,体重指数更高,更有可能接受过放射治疗,且手术后下丘脑损伤更严重。兴奋剂(莫达非尼、吡咯烷酮和哌醋甲酯)治疗对 9/10 的患者有益。
近一半患有睡眠障碍的颅咽管瘤患者存在中枢性过度睡眠障碍(发作性睡病和中枢性嗜睡症),这应该得到调查,并导致这些肥胖患者不仅仅考虑睡眠呼吸暂停综合征。